PharVision Advisers’s CuriosityStream CURI Stock Holding History

PharVision Advisers’s Portfolio CURI Stock Details CURI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,883	Closed	-$44.1K	–	77
2026 Q1	$44.1K	Sell	14,883 -91,189	-86%	-$308K	0.45%	91
2025 Q4	$403K	Buy	106,072 +59,132	+126%	+$263K	0.2%	121
2025 Q3	$249K	Buy	+46,940	New	+$216K	0.14%	334

Other funds holding CURI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

PharVision Advisers's CURI Position: Q2 2026 in Review

PharVision Advisers sold out of CuriosityStream (CURI) in Q2 2026, closing a stake of 14,883 shares — an estimated $44.1K sold.

PharVision Advisers first reported a position in CURI in Q3 2025 and held it in 3 quarters. The position peaked at $403K in Q4 2025. 102 funds tracked by Wall St. Rank hold CURI as of Q2 2026.

PharVision Advisers reported no remaining CuriosityStream position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 14,883 CuriosityStream shares in Q2 2026, an estimated $44.1K.
PharVision Advisers first reported a position in CuriosityStream in Q3 2025 and held it in 3 quarters.
PharVision Advisers's CuriosityStream position peaked at $403K in Q4 2025.
102 funds tracked by Wall St. Rank held CuriosityStream as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.